Targeted Therapy in Non-Small Lung Cancer. By D.E. Gerber. 2011, pp. 76, £9.99, ISBN: 978-0-19-974308-7. Oxford University Press, New York, NY, USA.
This Oxford American Pocket Note provides summarized knowledge on molecular target therapies in NSCLC providing information on EGFR inhibitors, antiangiogenic agents, erlotinib, cetuximab and bevacizumab including indications, dosage and administration, toxicities and outcome.
- Copyright© 2012 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved